APOE and Alzheimer disease: While the APOE4 effect on CSF Aβ1–42 levels is significant for both genders, its influence on AD risk is more significant in women than in men: Female carriers of the APOE4 allele exhibit widespread brain hypometabolism and cortical thinning when compared to female non-carriers.